A recent meta-analysis of 170 studies reported elevated peripheral levels of C-reactive protein (CRP), interleukin-6 (IL-6), interleukin-1 beta (IL-1β), soluble tumour necrosis factor receptor 1 and 2 (sTNFR-1 & sTNFR-2), interleukin-10 (IL-10), monocyte chemoattractant protein-1 (MCP-1) and transforming growth factor-1 (TGF-1) in individuals with an Alzheimer’s disease diagnosis compared to healthy controls (Shen et al., 2019). The gene discussed is CCL2; the disease is early-onset autosomal dominant Alzheimer disease.